Merck & Co., Inc. (MRK) News Today → #1 election stock (From Porter & Company) (Ad) Free MRK Stock Alerts $128.81 -0.41 (-0.32%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFirst Trust Direct Indexing L.P. Has $4.47 Million Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 1 at 7:21 PMMerck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinomafinance.yahoo.com - May 1 at 7:49 AMMerck & Co., Inc. Q1 Earnings Transcriptmarketbeat.com - May 1 at 7:06 AMIs Merck Stock Fully Valued At $130?forbes.com - May 1 at 6:14 AMRaymond James Financial Services Advisors Inc. Has $471.70 Million Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - May 1 at 12:50 AMMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - April 30 at 12:59 PMKestra Private Wealth Services LLC Purchases 12,477 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 29 at 9:50 PMMerck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adultsbusinesswire.com - April 29 at 9:00 AMFY2024 Earnings Estimate for Merck & Co., Inc. (NYSE:MRK) Issued By Cantor Fitzgeraldamericanbankingnews.com - April 29 at 3:16 AMLeerink Partnrs Analysts Cut Earnings Estimates for Merck & Co., Inc. (NYSE:MRK)americanbankingnews.com - April 29 at 1:42 AMBlue Chip Partners LLC Raises Stock Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 28 at 10:25 PMMerck & Co., Inc. (NYSE:MRK) PT Raised to $143.00 at Truist Financialamericanbankingnews.com - April 28 at 5:56 AMMerck & Co., Inc. (NYSE:MRK) Shares Acquired by PFG Investments LLCmarketbeat.com - April 27 at 9:58 PMMerck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Thinkfinance.yahoo.com - April 27 at 10:02 AMTruist Financial Corp Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 27 at 12:41 AMMerck & Co., Inc. (NYSE:MRK) Announces Quarterly Earnings Results, Beats Estimates By $0.13 EPSmarketbeat.com - April 26 at 3:51 PMTruist Financial Boosts Merck & Co., Inc. (NYSE:MRK) Price Target to $143.00marketbeat.com - April 26 at 12:52 PMBank Julius Baer & Co. Ltd Zurich Sells 1,166,230 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 25 at 8:21 PMMerck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlookbenzinga.com - April 25 at 12:55 PMHeard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharmafinance.yahoo.com - April 25 at 12:55 PMMerck's Cancer Drug and Vaccine Sales Drive Better-Than-Expected Resultsinvestopedia.com - April 25 at 11:36 AMMerck jumps on profit beat as Bristol Myers Squibb slips to a lossproactiveinvestors.com - April 25 at 9:51 AMMerck & Co., Inc. (NYSE:MRK) Issues FY24 Earnings Guidancemarketbeat.com - April 25 at 9:25 AMMerck’s first-quarter results beat expectations amid healthy vaccine-sales growthmarketwatch.com - April 25 at 7:55 AMMerck Lifts FY24 Outlook After Higher Q1 Earnings, Above Market; Stock Up In Pre-marketmarkets.businessinsider.com - April 25 at 7:55 AMMerck raises 2024 profit forecast on strong sales of cancer drug Keytrudafinance.yahoo.com - April 25 at 7:55 AMUPDATE 1-Merck raises 2024 profit forecast on strong sales of cancer drug Keytrudafinance.yahoo.com - April 25 at 7:55 AMMerck & Co., Inc. (NYSE:MRK) Releases FY 2024 Earnings Guidancemarketbeat.com - April 25 at 7:24 AMMerck raises 2024 profit forecast on strong cancer, HPV drugs salesreuters.com - April 25 at 6:33 AMMerck beats earnings expectations, raises outlook on strong Keytruda and vaccine salescnbc.com - April 25 at 6:32 AMMerck Announces First-Quarter 2024 Financial Resultsbusinesswire.com - April 25 at 6:30 AMPoplar Forest Capital LLC Sells 98,453 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 24 at 11:57 PMMerck Q1 Earnings Preview: Strong quarter expectations on the back of core products' growthmsn.com - April 24 at 12:11 PMBrokers Offer Predictions for Merck & Co., Inc.'s Q4 2025 Earnings (NYSE:MRK)americanbankingnews.com - April 24 at 2:56 AMAlaska Permanent Fund Corp Purchases 6,269 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 24 at 12:51 AMInvestor Alert: Prepare for the Market Crash With These 3 Stocksinvestorplace.com - April 23 at 5:11 PM3 Underappreciated Pharmaceutical Stocks to Buy Before They Surgeinvestorplace.com - April 23 at 3:00 PMHere’s Why Merck & Co. (MRK) Outperformed in Q1finance.yahoo.com - April 23 at 11:09 AMMerck & Co., Inc. (NYSE:MRK) Expected to Earn Q4 2025 Earnings of $2.39 Per Sharemarketbeat.com - April 23 at 6:31 AMIllinois Municipal Retirement Fund Has $51.80 Million Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 22 at 9:59 PMQ3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)americanbankingnews.com - April 22 at 1:52 AMFoundry Partners LLC Lowers Stock Holdings in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 21 at 10:35 PMCwm LLC Acquires 6,969 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 20 at 8:22 PMJ.W. Cole Advisors Inc. Acquires 8,241 Shares of Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 20 at 12:54 AMCramer's week ahead: Earnings from Tesla, Merck and Big Techcnbc.com - April 19 at 7:33 PMHealth Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapyfinance.yahoo.com - April 19 at 7:38 AMMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Fidelis Capital Partners LLCmarketbeat.com - April 18 at 7:04 PMCantor Fitzgerald Reiterates Overweight Rating for Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 18 at 10:35 AMDaiwa Securities Group Inc. Has $34.99 Million Position in Merck & Co., Inc. (NYSE:MRK)marketbeat.com - April 17 at 6:51 PMMerck Earnings Preview: Not Much To Fear, Plenty To Look Forward Toseekingalpha.com - April 17 at 3:52 PM Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar... Get your free information kit NOW, before it's too late. MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.680.35▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼4315▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AbbVie News Johnson & Johnson News Pfizer News Bristol-Myers Squibb News Eli Lilly and Company News AstraZeneca News Novartis News Abbott Laboratories News Sanofi News Vertex Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
